The global interventional cardiology market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients with cardiovascular diseases and the rising demand for minimally invasive procedures. The global interventional cardiology market by type includes cardiology catheters, guidewires, balloon catheters, coronary stents and fractional flow reserve devices. Cardiology catheters are used in diagnostic procedures such as angiography and cardiac mapping; guidewires are used in diagnostic procedures such as angiography; balloon catheters are used in diagnostic procedures such as angioplasty; coronary stents are used in treatment of blocked arteries; and fractional flow reserve devices are used for diagnosis of narrowed arteries. The application segment includes application I (diagnostic) and application II (treatment). Application I includes cardiac mapping, cardiac angiography, cardiac ablation therapy and other applications while application II includes percutaneous coronary intervention (PCI), percutaneous transluminal coronary angioplasty (PTCA) or ballooning procedure, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) or mitral valve repair procedure). North America is expected to dominate the global interventional cardiology market due to high prevalence rates for cardiovascular diseases among its population.
- The aging population is a major factor in the growth of the Interventional Cardiology market.
- The increasing prevalence of cardiovascular diseases is also a major factor in the growth of the Interventional Cardiology market.
- Increasing awareness about heart disease and its prevention is also a major factor in the growth of the Interventional Cardiology market.
- Increasing number of hospitals and healthcare facilities are investing in new technologies to improve patient care, which will lead to an increase in demand for interventional cardiologists, which will lead to an increase in demand for interventional cardiology services, which will lead to an increase in demand for interventional cardiology equipment, which will lead to an increase in demand for interventional cardiology consumables, all leading to increased revenue opportunities for companies operating within this industry over time as they continue investing into research and development activities that are focused on improving patient outcomes through innovative technologies that can be used during cardiac interventions such as angioplasty or stenting procedures or other procedures such as coronary artery bypass grafting (CABG) surgery or valve replacement surgery (VRS).
- Technological advancements have led to improved diagnostic capabilities and more accurate diagnosis rates with less invasive procedures than ever before; this has led many patients who would have otherwise been diagnosed with heart disease at later stages when it becomes more difficult and expensive to treat due to complications arising from advanced stages of heart disease being able to be diagnosed earlier on when it's easier and cheaper treatable by means of minimally invasive procedures such as angioplasty or stenting procedures or other procedures such as coronary artery bypass grafting (CABG) surgery or valve replacement surgery (VRS).
Industry Growth Insights published a new data on “Interventional Cardiology Market”. The research report is titled “Interventional Cardiology Market research by Types (Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound), By Applications (Application I, Application II), By Players/Companies Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE & Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA, OrbusNeich Medical, BV, Cordis Cashel, Kimal Plc, Volcano Corporation, Siemens Medical Solutions USA, Inc, Lepu, MicroPort ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Interventional Cardiology Market Research Report
By Type
Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound
By Application
Application I, Application II
By Companies
Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE & Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA, OrbusNeich Medical, BV, Cordis Cashel, Kimal Plc, Volcano Corporation, Siemens Medical Solutions USA, Inc, Lepu, MicroPortÂ
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Interventional Cardiology Market Report Segments:
The global Interventional Cardiology market is segmented on the basis of:
Types
Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Application I, Application II
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic, Inc.
- Boston Scientific Corporation
- Abbott Vascular
- MINVASYS S.A.S.
- BIOTRONIK SE & Co. KG
- Bard Peripheral Vascular?Inc
- TERUMO CORPORATION
- KANEKA
- OrbusNeich Medical, BV
- Cordis Cashel
- Kimal Plc
- Volcano Corporation
- Siemens Medical Solutions USA, Inc
- Lepu
- MicroPortÂ
Highlights of The Interventional Cardiology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiology catheters
- Guidewires
- Balloon catheters
- Coronary stents
- Fractional flow reserve
- Intravascular ultrasound
- By Application:
- Application I
- Application II
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Interventional Cardiology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Interventional cardiology is a type of cardiovascular medicine that uses medical devices and techniques to diagnose and treat heart disease. Interventional cardiologists may perform procedures such as angioplasty, stenting, or bypass surgery.
Some of the major companies in the interventional cardiology market are Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE & Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA, OrbusNeich Medical, BV, Cordis Cashel, Kimal‚Â Plc, Volcano Corporation, Siemens Medical Solutions USA, Inc, Lepu, MicroPort‚Â .
The interventional cardiology market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Interventional Cardiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Interventional Cardiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Interventional Cardiology Market - Supply Chain
4.5. Global Interventional Cardiology Market Forecast
4.5.1. Interventional Cardiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Interventional Cardiology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Interventional Cardiology Market Absolute $ Opportunity
5. Global Interventional Cardiology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Interventional Cardiology Market Size and Volume Forecast by Type
5.3.1. Cardiology catheters
5.3.2. Guidewires
5.3.3. Balloon catheters
5.3.4. Coronary stents
5.3.5. Fractional flow reserve
5.3.6. Intravascular ultrasound
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Interventional Cardiology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Interventional Cardiology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Interventional Cardiology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Interventional Cardiology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Interventional Cardiology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Interventional Cardiology Demand Share Forecast, 2019-2029
9. North America Interventional Cardiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Interventional Cardiology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Interventional Cardiology Market Size and Volume Forecast by Type
9.7.1. Cardiology catheters
9.7.2. Guidewires
9.7.3. Balloon catheters
9.7.4. Coronary stents
9.7.5. Fractional flow reserve
9.7.6. Intravascular ultrasound
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Interventional Cardiology Demand Share Forecast, 2019-2029
10. Latin America Interventional Cardiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Interventional Cardiology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Interventional Cardiology Market Size and Volume Forecast by Type
10.7.1. Cardiology catheters
10.7.2. Guidewires
10.7.3. Balloon catheters
10.7.4. Coronary stents
10.7.5. Fractional flow reserve
10.7.6. Intravascular ultrasound
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Interventional Cardiology Demand Share Forecast, 2019-2029
11. Europe Interventional Cardiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Interventional Cardiology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Interventional Cardiology Market Size and Volume Forecast by Type
11.7.1. Cardiology catheters
11.7.2. Guidewires
11.7.3. Balloon catheters
11.7.4. Coronary stents
11.7.5. Fractional flow reserve
11.7.6. Intravascular ultrasound
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Interventional Cardiology Demand Share, 2019-2029
12. Asia Pacific Interventional Cardiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Interventional Cardiology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Interventional Cardiology Market Size and Volume Forecast by Type
12.7.1. Cardiology catheters
12.7.2. Guidewires
12.7.3. Balloon catheters
12.7.4. Coronary stents
12.7.5. Fractional flow reserve
12.7.6. Intravascular ultrasound
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Interventional Cardiology Demand Share, 2019-2029
13. Middle East & Africa Interventional Cardiology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Interventional Cardiology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Interventional Cardiology Market Size and Volume Forecast by Type
13.7.1. Cardiology catheters
13.7.2. Guidewires
13.7.3. Balloon catheters
13.7.4. Coronary stents
13.7.5. Fractional flow reserve
13.7.6. Intravascular ultrasound
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Interventional Cardiology Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Interventional Cardiology Market: Market Share Analysis
14.2. Interventional Cardiology Distributors and Customers
14.3. Interventional Cardiology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott Vascular
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MINVASYS S.A.S.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BIOTRONIK SE & Co. KG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bard Peripheral Vascular?Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. TERUMO CORPORATION
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. KANEKA
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. OrbusNeich Medical, BV
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cordis Cashel
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Kimal Plc
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Volcano Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Siemens Medical Solutions USA, Inc
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Lepu
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. MicroPort
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook